These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 26341817)

  • 1. Silencing of DYRK2 increases cell proliferation but reverses CAM-DR in Non-Hodgkin's Lymphoma.
    Wang Y; Wu Y; Miao X; Zhu X; Miao X; He Y; Zhong F; Ding L; Liu J; Tang J; Huang Y; Xu X; He S
    Int J Biol Macromol; 2015 Nov; 81():809-17. PubMed ID: 26341817
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overexpression of TRIP6 promotes tumor proliferation and reverses cell adhesion-mediated drug resistance (CAM-DR) via regulating nuclear p27(Kip1) expression in non-Hodgkin's lymphoma.
    Miao X; Xu X; Wu Y; Zhu X; Chen X; Li C; Lu X; Chen Y; Liu Y; Huang J; Wang Y; He S
    Tumour Biol; 2016 Jan; 37(1):1369-78. PubMed ID: 26298725
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Upregulation of ADAM12 contributes to accelerated cell proliferation and cell adhesion-mediated drug resistance (CAM-DR) in Non-Hodgkin's Lymphoma.
    Yin H; Zhong F; Ouyang Y; Wang Q; Ding L; He S
    Hematology; 2017 Oct; 22(9):527-535. PubMed ID: 28395594
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of small glutamine-rich TPR-containing protein A (SGTA) in Non-Hodgkin's Lymphomas promotes tumor proliferation and reverses cell adhesion-mediated drug resistance (CAM-DR).
    Wang Y; Huang Y; Xu X; Tang J; Huang X; Zhu J; Liu J; Miao X; Wu Y; Yang F; Ji L; He S
    Leuk Res; 2014 Aug; 38(8):955-63. PubMed ID: 24974147
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Silencing of CKIP-1 promotes tumor proliferation and cell adhesion-mediated drug resistance via regulating AKT activity in non-Hodgkin's lymphoma.
    Zhu X; Ouyang Y; Zhong F; Wang Q; Ding L; Zhang P; Chen L; Liu H; He S
    Oncol Rep; 2017 Jan; 37(1):622-630. PubMed ID: 27840970
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sam68 regulates cell proliferation and cell adhesion-mediated drug resistance (CAM-DR) via the AKT pathway in non-Hodgkin's lymphoma.
    Wu Y; Xu X; Miao X; Zhu X; Yin H; He Y; Li C; Liu Y; Chen Y; Lu X; Wang Y; He S
    Cell Prolif; 2015 Dec; 48(6):682-90. PubMed ID: 26478515
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low Expression of DYRK2 (Dual Specificity Tyrosine Phosphorylation Regulated Kinase 2) Correlates with Poor Prognosis in Colorectal Cancer.
    Yan H; Hu K; Wu W; Li Y; Tian H; Chu Z; Koeffler HP; Yin D
    PLoS One; 2016; 11(8):e0159954. PubMed ID: 27532268
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Expression and correlation of Skp2 and p27(kip1) in 92 cases of non-Hodgkin's lymphoma].
    Lu JX; Zhang DM; Shen AG; Wang YC; He S; Shao XY; Liu HO; Cheng C
    Zhonghua Zhong Liu Za Zhi; 2007 May; 29(5):373-7. PubMed ID: 17892135
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ADP-ribosylation factor 1 (ARF1) takes part in cell proliferation and cell adhesion-mediated drug resistance (CAM-DR).
    Xu X; Wang Q; He Y; Ding L; Zhong F; Ou Y; Shen Y; Liu H; He S
    Ann Hematol; 2017 May; 96(5):847-858. PubMed ID: 28238095
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ENO1 promotes tumor proliferation and cell adhesion mediated drug resistance (CAM-DR) in Non-Hodgkin's Lymphomas.
    Zhu X; Miao X; Wu Y; Li C; Guo Y; Liu Y; Chen Y; Lu X; Wang Y; He S
    Exp Cell Res; 2015 Jul; 335(2):216-23. PubMed ID: 26024773
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DIXDC1 promotes tumor proliferation and cell adhesion mediated drug resistance (CAM-DR) via enhancing p-Akt in Non-Hodgkin's lymphomas.
    Ouyang Y; Zhong F; Wang Q; Ding L; Zhang P; Chen L; Wang Y; Cheng C
    Leuk Res; 2016 Nov; 50():104-111. PubMed ID: 27701018
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Downregulation of dual-specificity tyrosine-regulated kinase 2 promotes tumor cell proliferation and invasion by enhancing cyclin-dependent kinase 14 expression in breast cancer.
    Imawari Y; Mimoto R; Hirooka S; Morikawa T; Takeyama H; Yoshida K
    Cancer Sci; 2018 Feb; 109(2):363-372. PubMed ID: 29193658
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Upregulation of nuclear transporter, Kpnβ1, contributes to accelerated cell proliferation- and cell adhesion-mediated drug resistance (CAM-DR) in diffuse large B-cell lymphoma.
    He S; Miao X; Wu Y; Zhu X; Miao X; Yin H; He Y; Li C; Liu Y; Lu X; Chen Y; Wang Y; Xu X
    J Cancer Res Clin Oncol; 2016 Mar; 142(3):561-72. PubMed ID: 26498772
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [MicroRNA-138 regulates cell adhesion-mediated drug resistance phenotype by targeting SGTA in non-Hodgkin's lymphoma].
    Wu YX; He S; Xu XH
    Zhonghua Xue Ye Xue Za Zhi; 2018 Aug; 39(8):668-673. PubMed ID: 30180469
    [No Abstract]   [Full Text] [Related]  

  • 15. Expression of Foxo3a in non-Hodgkin's lymphomas is correlated with cell cycle inhibitor p27.
    Zhao Y; Fei M; Wang Y; Lu M; Cheng C; Shen A
    Eur J Haematol; 2008 Aug; 81(2):83-93. PubMed ID: 18363870
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of cyclin-dependent kinase inhibitor p27(Kip1) in AIDS-related diffuse large-cell lymphomas is associated with Epstein-Barr virus-encoded latent membrane protein 1.
    Gloghini A; Gaidano G; Larocca LM; Pierconti F; Cingolani A; Dal Maso L; Capello D; Franceschi S; Tirelli U; Libra M; Niu H; Dalla-Favera R; Carbone A
    Am J Pathol; 2002 Jul; 161(1):163-71. PubMed ID: 12107101
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of the Chaperonin containing t-complex polypeptide 1, subunit 8 (CCT8) in B-cell non-Hodgkin's lymphoma.
    Yin H; Miao X; Wu Y; Wei Y; Zong G; Yang S; Chen X; Zheng G; Zhu X; Guo Y; Li C; Chen Y; Wang Y; He S
    Leuk Res; 2016 Jun; 45():59-67. PubMed ID: 27101149
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Expression, localization and interrelationship of P27kip1 and cyclin D3 in non-Hodgkin's lymphoma].
    Zhang DM; Lu JX; Shen AG; Chen L; He S; Shao XY; Liu HO; Cheng C
    Zhonghua Xue Ye Xue Za Zhi; 2005 Dec; 26(12):723-7. PubMed ID: 16620575
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DYRK2 controls the epithelial-mesenchymal transition in breast cancer by degrading Snail.
    Mimoto R; Taira N; Takahashi H; Yamaguchi T; Okabe M; Uchida K; Miki Y; Yoshida K
    Cancer Lett; 2013 Oct; 339(2):214-25. PubMed ID: 23791882
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polo-like kinase 1 as a new target for non-Hodgkin's lymphoma treatment.
    Liu L; Zhang M; Zou P
    Oncology; 2008; 74(1-2):96-103. PubMed ID: 18547964
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.